News in Brief
Pharmacology - May 5
Roche's Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Roche's Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Pharmacology - May 3
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
wire - news in brief
Category
Results 1 - 50 of 418.
In universities, relationships between students and teachers play a key role in creating a conducive learning experience.
Improving the resilience of Switzerland’s energy supply
The new research project, SUstainable and Resilient Energy for Switzerland (SURE) launches today, Tuesday, 4 May.
The new research project, SUstainable and Resilient Energy for Switzerland (SURE) launches today, Tuesday, 4 May.
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study 1 Neovascular age-related macular degeneration account
Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study 1 Neovascular age-related macular degeneration account
Vaccination - personal values and group dynamics are decisive
How do you get more people to have vaccinations? Gudela Grote firmly believes that it's worth looking at team dynamics.
How do you get more people to have vaccinations? Gudela Grote firmly believes that it's worth looking at team dynamics.
Filtering dangerous diarrhoea pathogens out of drinking water
Their very small size means that rotaviruses are difficult to filter out of water. But these pathogens are among the leading causes of gastrointestinal infections, especially among children in developing countries.
Their very small size means that rotaviruses are difficult to filter out of water. But these pathogens are among the leading causes of gastrointestinal infections, especially among children in developing countries.
Scientists are developing a completely new "brain stress test" for evaluating the mental status of patients with Parkinson's disease, the second most prevalent neurodegenerative disease worldwide. It involves awakening the "ghosts" hidden in specific networks of the brain to predict the onset of hallucinations.
The JeuneS3 (Santé, Sécurité, Sexualité) programme, which focused on improving adolescent and youth sexual and reproductive health in four Francophone African countries, has come to a close after four successful years.
ANTICOV: Largest Clinical Trial in Africa to Test New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
A research and innovation project at the University of Bern aims to strengthen sustainable farming methods among smallholder families in Africa and Asia using digitally supported agricultural extension services.
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population. Therefore, seroprevalance has markedly increased since autumn of last year. Furthermore, the COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) is now publishing preliminary results regarding the effects that the pandemic and the measures implemented to contain it are having on the well-being and lifestyles of the population for the first time.
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population.
Over the past two decades, substantial progress has been made in reducing the global burden of malaria through vector control interventions and improved access to diagnosis and treatment.
A multidisciplinary Swiss team explored the future of urban digitization in its theoretical, technical, and legal dimensions by modeling the city of Sion with an innovative ScanVan.
World Laboratory Day 2021: Talent for top-level cancer research
In conjunction with World Laboratory Day 2021, Inselspital, Bern University Hospital and the University of Bern interview SNF Professor Dr. Georgia Konstantinidou about her work and recent findings to provide insight into a research laboratory. Cancer claims more than 42 000 lives in Switzerland every year.
In conjunction with World Laboratory Day 2021, Inselspital, Bern University Hospital and the University of Bern interview SNF Professor Dr. Georgia Konstantinidou about her work and recent findings to provide insight into a research laboratory. Cancer claims more than 42 000 lives in Switzerland every year.
Biomedical research without boundaries
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
Roche purchases shares in tender offer for GenMark Diagnostics, Inc
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
Science advice is crucial
The scientific community is taking a clear stand on the CO2 Act. Given their expertise, they are not only permitted, but obliged to do so, asserts Reto Knutti.
The scientific community is taking a clear stand on the CO2 Act. Given their expertise, they are not only permitted, but obliged to do so, asserts Reto Knutti.
The national innovation platform Switzerland Innovation is expanding in Eastern Switzerland with its latest addition, the Innovation Park East.
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
Since 15 April, it is official: The Technology Transfer Center for 3D Printing in Medical Technology - Swiss m4m Center, in short - meets the requirements of ISO standard 13485:2016; it is thus allowed to produce implants and instruments for human patients.
"Science Wire" gives access to latest science news from universities, research centers and R&D companies.Add this page to your bookmarks
News in Brief
Pharmacology - May 5
Roche's Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Roche's Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Pharmacology - May 3
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine